-
Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed-Phase Precipitate Formation in Biorelevant Medi
Author: Zhang, Miao; Zhang, Shudong; Wu, Bin; Zhang, Zhe; Hu, Qin; Wang, Lin; Liu, Dongyang
Journal: BIOPHARMACEUTICS & DRUG DISPOSITION. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bdd.70025
-
Pharmacokinetic Studies of a Novel c-Met Targeting PROTAC Drug Candidate Using UPLC-MS/MS Quantification Method
Author: Gao, Yan; Li, Xinyu; Xin, Chao; Su, Xiangdong; Ai, Lianfeng; Zeng, Jiangmeng; Liu, Shilin; Wang, Jinxu
Journal: BIOPHARMACEUTICS & DRUG DISPOSITION. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bdd.70022
-
Influences of Magnesium Isoglycyrrhizinate on the Pharmacokinetics of Almonertinib in Rats and Its Potential Mechanism
Author: Fu, Yuhao; Li, Ying; Li, Yajing; He, Xueru; Xun, Xuejiao; Dong, Zhanjun
Journal: BIOPHARMACEUTICS & DRUG DISPOSITION. 2025; Vol. , Issue , pp. -. DOI: 10.1002/bdd.70007
-
Inhibition Mechanism of Ketamine-Apatinib by CYP2C9 and 3A4: A Prediction of Possible Drug-Drug Interactio
Author: Zheng, Xiang; Chen, Haiyan; Lin, Dan; Hu, Guo-Xin; Zhou, Hongyu
Journal: BIOPHARMACEUTICS & DRUG DISPOSITION. 2025; Vol. , Issue , pp. -. DOI: 10.1002/bdd.70008
